Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GC3110A in Healthy Infants
NCT03285997Phase 3Unknown
- Sponsor
- GC Biopharma
- Start
- Sep 2017
- Primary completion
- May 2018
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of GC Flu Quadrivalent in influenza, sponsored by GC Biopharma. Status: unknown.
02
Drugs
GC Flu Quadrivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03285997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03285997.